tbuckley/cabot-search huggingface dataset:
Dummy Tablets
Authors: G. I. Watson
Journal: BMJ (1958)

Because of heavy pressure on our space, correspondents are asked to keep their letters short.Tabo-paresis SIR,-Some senior and experienced psychiatrists have re- cently had cause to give considerable thought to the topic of tabo-paresis.One British psychiatrist recently found that there was concern in responsible circles in America on the same topic.When the time-lag between primary infec- tion with syphilis and the onset of tabo-paresis is considered, it appears possible that the recent virtual disappearance of tabo-paresis is due to the efficiency of arsenical treatment in the years before the large-scale employment of antibiotics.It may be that cases treated in the early years of the antibiotic era have yet to develop tabo-paresis.The time factor suggests that the next few years may be particularly important in this respect.Recently a senior psychiatrist with considerable experience of neurosyphilis had four cases referred to him within a very short period-more cases than he had seen for a very long time previously.Two of these cases could easily have been missed by a more junior man with little practical experience of tabo-paresis.More- over, some of the old, characteristic physical signs seem to be changing somewhat.It may be hoped that fears of a reappearance of tabo- paresis on a considerable scale may prove groundless, but there appears to be reason for clinicians to be very alert on this topic, so that if an increase in the number of cases should occur the sufferers from it may be diagnosed early and therefore successfully treated.-I:am,etc.,
TNF Induces the Production of Type 2 Cytokines in Human Group 2 Innate Lymphoid Cells
Authors: Atsushi Kato, Noriko Ogasawara, Julie A. Poposki, Aiko I. Klingler, Kathryn E. Hulse, Bruce K. Tan, Whitney W. Stevens, Anju T. Peters, Leslie C. Grammer, Kevin C. Welch, Stephanie S. Smith, David B. Conley, Robert C. Kern, Robert P. Schleimer
Journal: Journal of Allergy and Clinical Immunology (2019)
Value of hyperbaric oxygen in suspected carbon monoxide poisoning
Authors: R. A. Myers
Journal: JAMA (1981)

The cases of four patients included sufficient circumstantial evidence to suspect carbon monoxide poisoning as the principal etiologic agent, although the diagnosis was unconfirmed. In two other patients, CO poisoning was proven by elevated carboxyhemoglobin levels. All six patients were transferred from outlying hospitals for failure to respond adequately to standard therapy and recovered completely following treatment with hyperbaric oxygen. Hyperbaric oxygen should be used for severe cases of suspected CO poisoning, regardless of the time between exposure and presentation, especially when the delay is sufficient to preclude a diagnosis by standard laboratory methods. (<i>JAMA</i>1981;246:2478-2480)
Leads from the MMWR. AIDS and HIV update: acquired immunodeficiency syndrome and human immunodeficiency virus infection among health-care workers
Journal: JAMA (1988)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Relation Between Pediatrics and General Medicine*
Journal: JAMA (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
TENTH ANNUAL REPORT OF THE STATE BOARD OF HEALTH OF ILLINOIS, SPRINGFIELD, 1890. REPORT ON MEDICAL EDUCATION, MEDICAL COLLEGES, AND THE REGULATION OF THE PRACTICE OF MEDICINE IN THE UNITED STATES, 1890.
Journal: JAMA (1890)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Ethical aspects of banking placental blood for transplantation
Authors: J. Sugarman
Journal: JAMA (1995)

Transplantation of blood cells harvested from the umbilical cord immediately after birth has been effective in repopulating the bone marrow. These placental blood transplantations may be safer than conventional bone marrow transplantations and may suspend the need to harvest bone marrow, a process fraught with difficulties. Further understanding and advancement of this emerging technology require developing large banks of placental blood. In this article, we examine some of the ethical issues associated with placental blood banking, including (1) questions about ownership of the tissue, (2) the necessity and nature of obtaining informed consent from parents for harvesting placental blood and the information-gathering process associated with it, (3) obligations to notify parents and children of the results of medical testing for infectious diseases and genetic information, (4) matters of privacy and confidentiality related to such information, and (5) the need for fair and equitable harvesting of and access to placental blood. (<i>JAMA</i>. 1995;274:1783-1785)
THE FINANCIAL WANING OF DOWIEISM.
Journal: JAMA (1903)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Studies on Preparation and Nature of a Gastric Secretagogue of Pancreatic Origin
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Telemedicine Report
Journal: JAMA (1996)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Three linked editorials
Authors: Richard Smith, Jane Smith, Fiona Godlee, Annabel Ferriman, Susan Mayor, Linda Beecham, Sandra Goldbeck-Wood, Alison Tonks General, Trish Groves, Kamran Abbasi, Luisa Dillner, Tessa Richards, Liz Crossan, Linda Reviews, Douglas Carnall, Gaby Shockley, Margaret Benfell, Andrew Woodward, John Gary, Bryan Standing, Richard Harling, Marcus Müllner, Susan Minns, Marita Batten Picture, Jan Science, Abi Berger, Margaret Cooter, Jackie Annis, Greg Cotton, Sharon Davies, Liz Payne, Miriam Pinchuk, Julia Thompson, Tony Delamothe, Christopher Martyn, Roger Robinson, Tony Smith, Gwen Adshead, James Barrett, Nicky Britten, Angela Coulter, Teifion Davies, Robin Ferner, Ian Forgacs, Trish Greenhalgh, Marcia Hall, Iona Heath, Richard Hobbs, David Jewell, Kevin Jones, Duncan Keeley, Tim Lancaster, Ben Lloyd, Diana Lockwood, Azeem Majeed, Michael O'brien, John Rees, Nicholas Steel, Sheila Teasdale, Tom Treasure, Chris Van Weel, John Williams, Jeremy Wyatt, Doug Altman, Mike Campbell, Tim Cole, Jon Deeks, Stephen Evans, David Machin, Ken Macrae, Julie Morris, Jackie Connor, Andy Josephides, Bernadette Kearney, Catherine Harding-Wiltshire, Nick Supple, Steve Mcauley, Simon Walker, Alan Walker, Sheila Rowe, David Evans, Jennifer Leaning, Rajendra Kale, George Alberti, Jeremy Anderson, Tony Culyer, Alba Dicenso, Canada Dixon, Paul Glasziou, Heather Australia, Peter Goodare, Tony Denmark, Brian Grabham, Canada Haynes, Canada Kjellstrand, Christian Knottnerus, Cindy Austria, Hong Lam, Alessandro Kong, Dennis Liberati, David Mant, U Jean, Claude Mbanya, Indraneel Cameroon, India Mittra, David Mulrow, Canada Naylor, John Roberts, Paula Rochon, Canada Savill, Jaime Sepulveda, Fiona Stanley, Tessa Australia
Journal: BMJ (1998)
BOOK REVIEWS
Authors: M. P. OSBORNE
Journal: JNCI Journal of the National Cancer Institute (1989)

BOOK REVIEWS Get access Breast Cancer: Collaborative Management. J. K. Harkness, H.A. Oberman, A.S. Lichter, D.D. Adler, R.L. Cody, eds. Chelsea, MI: Lewis Publishers, Inc., 1988, 381 pp. $69.95 MICHAEL P. OSBORNE MICHAEL P. OSBORNE Breast Service Memorial Sloankettering Cancer Center1275 York Ave. New York, NY 10021 Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 81, Issue 2, 18 January 1989, Pages 165–166, https://doi.org/10.1093/jnci/81.2.165 Published: 18 January 1989
Effective guidelines take implementation into account
Journal: BMJ (1998)

No link exists between exposure to benzodiazepines in pregnancy and cleft palateConflicting evidence exists about whether first trimester exposure to benzodiazepines increases the risk of major malformations or oral cleft.In their metaanalysis of cohort trials Dolovich et al (p 839) found that fetal exposure to benzodiazepines was not associated with major malformations or oral cleft, but a smaller pooled analysis on the basis of data from casecontrol studies found a significantly increased risk for major malformations or oral cleft.Even if the "worst case scenario" is assumed, benzodiazepines do not seem to be major human teratogens.
"Fasting " Exhibitions Condemned.—
Journal: JAMA (1892)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Mycotic Infections
Authors: John Godwin Downing, Norman F. Conant
Journal: New England Journal of Medicine (1945)

Systemic MycosesIncluded in this category are diseases caused by a wide variety of fungi, each of which may invade any tissue of the body, producing widespread infection resulting in death. These fungi induce a granulomatous type of infection, and differential diagnosis must include tuberculosis, syphilis, granulomas and neoplasms. Coccidioidomycosis This is a highly infectious disease caused by Coccidioides immitis that produces a high incidence of infection, as shown by positive skin tests with coccidioidin, among native populations in the endemic areas of the San Joaquin Valley in California, around Phoenix and Tucson in Arizona and around San Angelo in . . .
Hans Queckenstedt (1876-1918), neurophysiologist
Journal: JAMA (1968)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Massachusetts Medical Society
Authors: Frank N. Allan, George Ballantyne, Joseph Rosenthal, James Townsend, Priscilla White, Howard F. Root
Journal: New England Journal of Medicine (1949)

DIABETES DETECTION — A STATEMENT OF THE COMMITTEE ON DIABETESThe existence of a large number of persons with diabetes undiagnosed and therefore untreated has been demonstrated by surveys not only in Massachusetts but elsewhere. There is need for the dissemination among physicians of information about the recent methods of treatment of diabetes by means of programs in district-society and hospital meetings. There is also a great opportunity and need to convey information to the public about the service the physician can give to patients with diabetes in all stages of the disease, but particularly during the early stage. This . . .
A phase I study of nilotinib alone and in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors (GIST): Study update
Authors: J. Y. Blay, P. G. Casali, P. Reichardt, M. von Mehren, M. Debiec-Rychter, S. Bailey, M. L. Veronese, G. D. Demetri
Journal: Journal of Clinical Oncology (2008)

10553 Background: A previous analysis of a phase I study demonstrated that nilotinib has promising clinical activity in patients (pts) with GIST who are resistant to prior tyrosine kinase inhibitors (TKIs) including imatinib. The current analysis of a phase 1 study reports on the efficacy and long-term safety of nilotinib alone and in combination with IM. Methods: Pts with imatinib-resistant GIST received nilotinib alone (400 mg orally BID) or escalating doses of nilotinib (200 mg QD, 400 mg QD, or 400 mg BID) in combination with IM (400 mg orally BID), or nilotinib 400 mg BID plus IM 400 mg QD. Results: A total of 53 pts received nilotinib, alone (n = 18, 5 IM-intolerant) or in combination with IM (n = 35). Thirty-nine pts (74%) were resistant, refractory, and/or intolerant to one or more prior therapies. Sixteen pts received combination therapy at the nilotinib 400 mg BID/IM 400 mg QD dose (N 400BID/IM 400QD). Median duration of therapy in this combination arm was 217 days (range, 27–492) versus 186 days (range, 8–718) for nilotinib alone. Grade 3/4 AEs were experienced by 9 (50%) pts in the nilotinib alone arm and 7 (44%) pts in the N 400BID/IM 400QD arm. The most common of these was grade 3 GI disorders, which occurred in 8 (44%) pts in the nilotinib alone arm and 2 (12.5%) pts in the N 400BID/IM 400QD arm. One pt on nilotinib alone experienced dose- limiting hyperbilirubinemia; 3 patients on N 400BID/IM 400QD experienced dose-limiting rash. No patients experienced QTcF > 500 msec. Two pts, one on nilotinib alone and one in the N 400BID/IM 400QD arm, achieved partial response (PR) lasting 197 days and 176 days, respectively. Thirteen pts (72%) and 9 pts (56%) in the nilotinib alone and N 400BID/IM 400QD cohorts, respectively, experienced stable disease (SD). Median progression-free survival was 168 days for nilotinib alone and 203 days for N 400BID/IM 400QD. Median duration of disease control (CR, PR or SD) was 158 days for nilotinib alone and 259 days for the N 400BID/IM 400QD cohort. Conclusions: Nilotinib, alone and in combination with IM, has significant activity in pts with GIST who are resistant to prior TKIs. The efficacy and safety of nilotinib in third- line GIST are being studied in an ongoing phase III trial. Author Disclosure Employment or Leadership Consultant or Advisory Role Stock Ownership Honoraria Research Expert Testimony Other Remuneration Novartis Amgen, Bayer, GlaxoSmithKline, Infinity, MedImmune, Novartis, Pfizer, PharmaMar, Roche, sanofi-aventis GlaxoSmithKline, MedImmune, Novartis, Pfizer, PharmaMar, Roche, SigmaTau Amgen, Bristol-Myers Squibb, Infinity, Jansen Cilag, Novartis, OSI Oncology, Pfizer, SigmaTau Infinity, Novartis, Pfizer Novartis, PharmaMar
THE PRESENCE OF DIPHTHERIA BACILLI IN HEALTHY PERSONS.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal